Dentronic

Summary

About

About Dentronic

Dentronic is developing Dexor as a chairside robotic assistant that holds and positions dental instruments during treatment. The arm is intended to perform repetitive functions such as suction, cheek or tongue retraction and maintaining access to the treatment area. Perception and force-aware control must keep the instrument aligned while the patient and clinician move, without obstructing the dentist’s working space.

A clinician selects or supervises the required assistance behaviour while retaining responsibility for the procedure. Dexor’s role is to replace the second pair of hands needed to maintain suction or tissue position, allowing a dentist or hygienist to complete selected workflows with less dependence on continuous chairside support. Dentronic is building the robot, control software and clinical interface as one system and is in product development and clinical validation before broad commercial deployment.

PRICE
Range 1Y
Return
High
Low
Updated

Products

Funding

Investors

  • Krew Capital - Participant - VC - 1 funding event - first seen 2026-03-19
  • South Park Commons - Participant - Unknown - 1 funding event - first seen 2026-03-19

Team

  • Kyoungyeon Choi - Co-Founder and CEO
  • Soy Choi - Co-Founder
  • Minjun Lee - Co-Founder

Timeline

Events

  • 2026-03-19 - Funding - Dentronic secures $1M pre-seed funding to scale Dexor dental robotics system

    Dentronic announced an approximately $1 million pre-seed round after selection into South Park Commons' Founder Fellowship, following earlier backing from Krew Capital. The funding supports full-scale development of Dexor, Dentronic's chairside robotic arm for repetitive dental assistance tasks such as suction and retraction. The company says its first 50-unit Dexor batch sold out and is now moving toward broader production.

    Source